Skip to main content

Table 1 Variable overview

From: Neurobiological mechanisms of ECT and TMS treatment in depression: study protocol of a multimodal magnetic resonance investigation

 

Timepoints (TP) for analyses

TP1

TP2

TP3

TP4

TP5

Timepoints relative to treatment

Baseline, before treatment

During treatment

After treatment

Timeframe for each test

 < 7 d of first ECT/TMS

1–2 h before first ECT/TMS

1–2 h after first ECT/TMS

before 7th ECT/11th TMS

7–14 d after last ECT/TMS

6 mo after ECT/TMS series

Clinical assessments c

Clinical examination

x

     

ECT- stimulus specific measures b

EEG, pulse width, charge, amplitude, frequency, pulse train duration, seizure duration, electrode placement and reorientation time

 

x

 

x

  

Current and concomitant medication

x

  

x

x

x

Symptom severity c

MADRS [47]

x

  

x

x

x

BDI [48]

x

  

x

x

x

CGI [49]

x

  

x

x

x

EMQ [50]

x

  

x

x

x

MMSE [51]

      

Radiology

MRI: T1, T2, MRS, ASL, DWI, rsfMRI

 

x

x

x

x

x

Neurocognitive assessments aligned with GEMRIC recommendation

1. RAVLT [52, 53]

x

   

x

x

2. Phonemic Fluency [54]

x

   

x

x

3. Semantic Fluency [54]

x

   

x

x

4. SDMT [55]

x

   

x

x

5. TMT A + B [54]

x

   

x

x

7. DSB [55]

x

   

x

x

8. AMT [56]

x

   

x

x

9. MoCa version 7.1 [57]

x

   

x

x

10. NART [58]

x

   

x

x

11. QIDS-SR 16 [59]

x

   

x

x

Study specific neurocognitive assessments

1.VAMSa,c [60]

x

   

x

x

3. Spatial navigation: Memory retrieval task [61, 62], Four Mountain [63], Sea Hero [64]

x

   

x

x

4. RCFT [65]

x

   

x

x

5. CWIT [54]

x

   

x

x

6. PDQ-5 [66, 67] c

x

   

x

x

7. ECCA [68] c

x

   

x

x

Brain laterality, cognitive control

iDichotic [69, 70]

x

   

x

x

Blood samples

Serum, EDTA, PAX-gen

 

x

 

x

x

x

Actigraphy

Empatica 4 [71] b

x

 

x

x

x

x

  1. Abbreviations: TP Timepoint, MADRS Montgomery Åsberg Depression Rating Scale, BDI Beck Inventory test, CGI Global Impression Scale, EMQ Everyday Memory Questionary, MMSE Mini Mental Status, RAVLT Rey Auditory Verbal Learning Test, F-A-S Phonemic Fluency, SDMT Symbol Digit Modality Test, TMT Trail Making Test, DSB Digit Span Backwards, AMT Autobiographical Memory Test, NART National Adult Reading Test, QIDS-SR 16 Quick Inventory of Depressive Symptomatology (16-item) (Self-Report), VAMS Visual Analog Mood Scale, RCFT Rey-Osterrieth Complex Figure Test, CWIT Color Word Interference Test, EEG electroencephalografy, PDQ-5 Perceived Deficits Questionary – Depression 5-item, ECCA Electroconvulsive Cognitive Assessment, iDichotic Dichotic listening, EDTA Ethylene Diamine-Tetra-acetic Acid, PAX-gen PAXgene Blood RNA tube, Empatica 4 Actigraphy with a wristband; MRS Magnetic Resonance Spectroscopy, ASL Arterial Spin Labeling, DWI Diffusion Weighted Imaging, rsfMRI Resting state functional magnetic resonance imaging
  2. aRepeated before and after each treatment
  3. bRepeated at each ECT treatment, TMS patients follow the same timepoints as the ECT patients
  4. cWill not be assessed for healthy controls